PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy
Molecularly targeted cancer therapies substantially improve patient outcomes, although the
durability of their effectiveness can be limited. Resistance to these therapies is often related …
durability of their effectiveness can be limited. Resistance to these therapies is often related …
Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders
GR Leitner, TJ Wenzel, N Marshall… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Adverse immune activation contributes to many central nervous system (CNS)
disorders. All main CNS cell types express toll-like receptor 4 (TLR 4). This receptor is …
disorders. All main CNS cell types express toll-like receptor 4 (TLR 4). This receptor is …
Glucose metabolism and AD: evidence for a potential diabetes type 3
A González, C Calfío, M Churruca… - Alzheimer's research & …, 2022 - Springer
Background Alzheimer's disease is the most prevalent cause of dementia in the elderly.
Neuronal death and synaptic dysfunctions are considered the main hallmarks of this …
Neuronal death and synaptic dysfunctions are considered the main hallmarks of this …
Altered expression of the m6A methyltransferase METTL3 in Alzheimer's disease
H Huang, J Camats-Perna, R Medeiros, V Anggono… - Eneuro, 2020 - eneuro.org
Cognitive impairment in Alzheimer's disease (AD) is associated with dysregulation of the
RNA and protein expression profiles in the brain. Recent studies have highlighted the …
RNA and protein expression profiles in the brain. Recent studies have highlighted the …
Discovery and characterization of highly potent and selective allosteric USP7 inhibitors
G Gavory, CR O'Dowd, MD Helm, J Flasz… - Nature chemical …, 2018 - nature.com
Given the importance of ubiquitin-specific protease 7 (USP7) in oncogenic pathways,
identification of USP7 inhibitors has attracted considerable interest. Despite substantial …
identification of USP7 inhibitors has attracted considerable interest. Despite substantial …
Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics
A Kulkarni, K Preeti, KP Tryphena, S Srivastava… - Ageing Research …, 2023 - Elsevier
The protein dyshomeostasis is identified as the hallmark of many age-related
neurodegenerative disorders including Parkinson's disease (PD). The diseased brain shows …
neurodegenerative disorders including Parkinson's disease (PD). The diseased brain shows …
SQSTM1/p62: a potential target for neurodegenerative disease
Neurodegenerative diseases, characterized by a progressive loss of brain function, affect
the lives of millions of individuals worldwide. The complexity of the brain poses a challenge …
the lives of millions of individuals worldwide. The complexity of the brain poses a challenge …
Persistent remodeling and neurodegeneration in late-stage retinal degeneration
Retinal remodeling is a progressive series of negative plasticity revisions that arise from
retinal degeneration, and are seen in retinitis pigmentosa, age-related macular …
retinal degeneration, and are seen in retinitis pigmentosa, age-related macular …
Post-translational modifications: regulators of neurodegenerative proteinopathies
One of the hallmark features in the neurodegenerative disorders (NDDs) is the accumulation
of aggregated and/or non-functional protein in the cellular milieu. Post-translational …
of aggregated and/or non-functional protein in the cellular milieu. Post-translational …
Pharmacological modulation of ubiquitin-proteasome pathways in oncogenic signaling
The ubiquitin-proteasome pathway (UPP) is involved in regulating several biological
functions, including cell cycle control, apoptosis, DNA damage response, and apoptosis. It is …
functions, including cell cycle control, apoptosis, DNA damage response, and apoptosis. It is …